NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Statement in Response to Recent ASCO Guidelines on Biomarker Assay Use in Adjuvant Breast Cancer Care
Agendia is disappointed with the recent update to the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines and with the decision to move forward without key research that we feel would have a material Read More
Agendia and Partners Receive $6.8 million from European Commission to Study Targeted Therapies for Colorectal Cancer
IRVINE, CA and AMSTERDAM, THE NETHERLANDS โ Agendia, Inc. and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer (CRC). The grantees will test therapies matched Read More
Agendiaโs MammaPrint and BluePrint Breast Cancer Tests to Be Highlighted at San Antonio Symposium
Satellite Symposium and Dinner Presentation Will Offerย Latest Insights on Genomic Testing and Molecular Subtyping IRVINE, CA and AMSTERDAM, THE NETHERLANDS โ New breast cancer research highlighting the value of Agendiaโs MammaPrintยฎ and BluePrintยฎ genomic tests Read More